IA
HZNP

Icon Advisers’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Icon Advisers’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-29,700
Closed -$1.84M – 164
2022
Q3 		$1.84M Buy
+29,700
New +$2.08M 0.5% 76
2017
Q2 		– Sell
-62,300
Closed -$921K – 435
2017
Q1 		$921K Buy
62,300
+46,700
+299% +$756K 0.06% 286
2016
Q4 		$252K Sell
15,600
-19,400
-55% -$352K 0.02% 392
2016
Q3 		$635K Buy
+35,000
New +$684K 0.04% 343

Other funds holding HZNP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return